▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #328 by analyst upside · 2026-11-12
HIND
Vyome Holdings, Inc.
Healthcare · Market Cap $11M · P/E 0.9x
ANALYST PRICE TARGET
+462.6%
implied upside to consensus target
Current Price $1.57
Consensus Target $8.83
Bull Target $15.0
Bear Target $3.5
Analysts Covering 3
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
2
Hold
0
Sell
0
52-Week Low $1.53
52-Week High $5.88
YTD Return -55.8%
FUNDAMENTALS
Market Cap $11M
P/E Ratio (TTM) 0.9x
Forward P/E N/A
EPS (TTM) $1.81
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $0M
Profit Margin N/A
52-WEEK RANGE
52-Week Low $1.53
52-Week High $5.88
Current Price $1.57
Bear Target $3.5
Bull Target $15.0
● Now $1.57 ● Target $8.83
TRADING DATA
Avg Volume 14K
YTD Return -55.8%
Analyst Count 3
Consensus Buy
Upside to Target +462.6%
Last Updated 2026-11-12

ANALYST SUMMARY

Vyome Holdings, Inc. (HIND) is currently trading at $1.57 with a Wall Street consensus price target of $8.83, implying potential upside of 462.6% over the next 12 months. 3 analysts currently cover HIND, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $15.0, while the most cautious has a target of $3.5.

HIND operates in the Healthcare sector with a market capitalisation of $11M. The stock is down 55.8% year-to-date and is currently trading near the lower end of its 52-week range of $1.53 – $5.88.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for HIND, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Chardan Capital ● Initiated
Buy 2026-09-03 33% win rate (6 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
38
out of 100
Coverage depth
11/30
Consensus clarity
0/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →